Photodynamic Therapy for Hidradenitis Suppurativa



Hidradenitis suppurativa is a chronic, often suppurative dermatologic disorder that has been shown to principally affect apocrine gland-bearing skin. Hidradenitis suppurativa is a disease that has often been misdiagnosed, not adequately studied by clinical researchers, and often not appropriately treated by clinicians. Hidradenitis suppurativa is a difficult to treat dermatologic disorder. ALA-PDT and MAL-PDT can be used to improve the lives of those affected with hidradenitis suppurativa.


Sinus Tract Dermatologic Life Quality Index Hidradenitis Suppurativa Apocrine Gland Drug Incubation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Gordon SW. Hidradenitis Suppurativa: a closer look. J Natl Med Assoc. 1978;70:339–43.PubMedGoogle Scholar
  2. 2.
    Velpeau A. Dictionnaire De Médecine, Un Répertoire Général Des Sciences Médicales Sous La Rapport Théorique Et Practique. Vol. 2, 2nd ed. Paris: Bechet Jeune; 1833: 91–109; Aiselle, 1833.Google Scholar
  3. 3.
    Robin C. Note sur une espece particuliere de glandes de la peau de l’homme. Troisieme serie Zoologie Ann sc nat Paris. 1845;4:380.Google Scholar
  4. 4.
    Verneuil A. De l’hidrosadenite phlegmoneuse et des abces sudoripares. Arch Gen Med. 1854;2:537–57.Google Scholar
  5. 5.
    Shelley WB, Cahn MM. The pathogenesis of hidradenitis suppurativa. Arch Dermatol. 1955;72: 562–5.Google Scholar
  6. 6.
    Kligman AM, Plewig G. Classification of acne. Cutis. 1976;17(3):520–2.PubMedGoogle Scholar
  7. 7.
    Yu CC, Cook MG. Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands. Br J Dermatol. 1990;122(6):763–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Attanoos RL, Appleton MA, Douglas-Jones AG. The pathogenesis of hidradenitis suppurativa: a closer look at apocrine and apoeccrine glands. Br J Dermatol. 1995;133(2):254–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Layton AM, Pace D, Cunliffe WJ, Barth J. A perspective histological study of acute hidradenitis suppurativa. Br J Dermatol. 1995;131(s44):38–9.Google Scholar
  10. 10.
    Jemec GB, Hansen U. Histology of hidradenitis suppurativa. J Am Acad Dermatol. 1996;34(6):994–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Harrison BJ, Mudge M, Hughes LE. The prevalence of hidradenitis suppurativa in South Wales. In: Marks R, Plewig G, editors. Acne and related disorders. London: Martin Dunitz; 1991. p. 365–6.Google Scholar
  12. 12.
    Naldi L. Epidemiology. In: Jemec G, Revuz J, Leyden J, editors. Hidradenitis suppurativa. 1st ed. Heidelberg: Springer; 2006. p. 58–64.CrossRefGoogle Scholar
  13. 13.
    Wiltz O, Schoetz Jr DJ, Murray JJ, Roberts PL, Coller JA, Veidenheimer MC. Perianal hidradenitis suppurativa. The Lahey Clinic experience. Dis Colon Rectum. 1990;33(9):731–4.PubMedCrossRefGoogle Scholar
  14. 14.
    Fitzsimmons JS, Guilbert PR. A family study of hidradenitis suppurativa. J Med Genet. 1985;22(5): 367–73.PubMedCrossRefGoogle Scholar
  15. 15.
    Sartorius K, Lapins J, Emtestam L, Jemec GB. Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol. 2003;149(1):211–3.PubMedCrossRefGoogle Scholar
  16. 16.
    Von der Werth JM, Williams HC, Raeburn JA. The clinical genetics of hidradenitis suppurativa revisited. Br J Dermatol. 2000;142:947–57.CrossRefGoogle Scholar
  17. 17.
    Galen WK, Cohen I, Roger M, Smith H. Bacterial infections. In: Schachner LA, Hansen RC, editors. Pediatric dermatology. 2nd ed. New York: Churchill Livingstone; 1996. p. 1206–7.Google Scholar
  18. 18.
    Von der Werth JM, Jemec GB. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol. 2001;144(4):809–13.PubMedCrossRefGoogle Scholar
  19. 19.
    Breitkopf C, Bockhorst J, Lippold A. Pyodermia fistulans sinifica (akne inversa) und eauchgewohnheiten. Z Haut. 1995;70: 332–4.Google Scholar
  20. 20.
    Morgan WP, Leicester G. The role of depilation and deodorants in hidradenitis suppurativa. Arch Dermatol. 1982;118(2):101–2.PubMedCrossRefGoogle Scholar
  21. 21.
    Gold MH, Bridges TM, Bradshaw VL, Boring M. ALA-PDT and blue light therapy for hidradenitis suppurativa. J Drugs Dermatol. 2004;3(1 suppl):32–9.Google Scholar
  22. 22.
    Von der Werth JM, Williams HC. The natural history of hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2000;14(5):389–92.PubMedCrossRefGoogle Scholar
  23. 23.
    Sellheyer K, Krahl D. “Hidradenitis suppurativa” is acne inversa! an appeal to (finally) abandon a misnomer. Int J Dermatol. 2005;44(7):535–40.PubMedCrossRefGoogle Scholar
  24. 24.
    Revuz J. Medical treatments of hidradenitis suppurativa: a new paradigm. Dermatology. 2007;215(2): 95–6.PubMedCrossRefGoogle Scholar
  25. 25.
    Gold MH, Goldman MP. 5-Aminolevulinic acid photodynamic therapy: where we have been and where we are going. Dermatol Surg. 2004;30:1077–84.PubMedCrossRefGoogle Scholar
  26. 26.
    Strauss RM, Pollock B, Stables GI, Goulden V, Cunliffe WJ. Photodynamic therapy using aminolaevulinic acid does not lead to improvement in hidradenitis suppurativa. Br J Dermatol. 2005;152:803–4.PubMedCrossRefGoogle Scholar
  27. 27.
    Rivard J, Ozog D. Henry Ford Hospital dermatology experience with Levulan Kerastick and blue light photodynamic therapy. J Drugs Dermatol. 2006;5(6): 556–61.PubMedGoogle Scholar
  28. 28.
    Schwiger ES, Riddle CC, Aires DJ. 20% Aminolevulinic acid photodynamic therapy to treat hidradenitis suppurativa: description and interim results of a pilot clinical study. J Am Acad Dermatol. 2008;58(2):P428 [abstr].Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Gold Skin Care Center, Tennessee Clinical Research CenterNashvilleUSA
  2. 2.Department of DermatologyVanderbilt University School of Medicine and Vanderbilt University School of NursingNashvilleUSA

Personalised recommendations